UltraPlex
UltraPlex pioneering sustainable and cost-efficient liposome-based RNA therapeutics delivery.
Status:
Pre-business
SDGs:
Good health and well-being
Industry:
Life science and medical
Impact:
Quality of life
Origin:
Research to Business
School:
School of Science
Established:
2025
The UltraPlex project develops a next-generation liposome-based drug delivery system for RNA therapeutics that is sustainable, cost-efficient, and scalable for pharmaceutical applications. Traditional liposomal formulations face challenges such as high production costs, solvent dependency, material waste, and therapeutic molecule encapsulation inefficiency issues, limiting their commercial viability. UltraPlex addresses these challenges by integrating green chemistry, nanotechnology, and focused ultrasound principles to create an eco-friendly and efficient drug delivery platform.
Contact
Christopher Fogarty
Business Developer
Read more about innovation services
News from innovation ecosystem
UniSport services at Aalto University facilities in autumn 2026
UniSport services for students and staff
Take a break! -break exercises on Tuesdays at campus in Autumn 2026
UniSport welcomes all aaltonians to participate and enjoy relaxing breaks in the free sessions of Take a break! -break exercises.
Would you like a small piece of future design history — shimmering wood?
Coming to the Aalto University Shop this September: a limited batch of 20 unique, handmade works by Shimber, crafted entirely from wood. Each piece is finished with Shimber’s wood‑based structural colour — a material that makes the surface shimmer and come alive with the light.